Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of subcutaneous injection of Human BNP
(nesiritide), a hormone produced by the heart, on the pumping ability of the heart, kidney
function, and hormonal function in persons with heart failure.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Horng Chen
Collaborators:
American Heart Association National Center for Research Resources (NCRR) National Heart, Lung, and Blood Institute (NHLBI) Scios, Inc.